Chronic Inflammation: The Common Thread Between Obesity, Insulin Resistance, and Cancer Risk

Acute inflammation is protective and necessary. The swelling around a cut, the fever triggered by infection, the pain that indicates tissue damage — these are the immune system operating correctly. They resolve, and the tissue returns to homeostasis.

Chronic, low-grade inflammation is different. It is not a response to a specific injury. It is a sustained, diffuse inflammatory state — characterized by elevated circulating inflammatory cytokines (IL-6, TNF-α, CRP) — driven by metabolic dysfunction, visceral fat accumulation, and the same caloric surplus that produces obesity.

Visceral Fat as an Inflammatory Organ

Adipose tissue is not metabolically inert. Adipocytes (fat cells) secrete hormones and cytokines collectively called adipokines. Visceral fat — the fat surrounding abdominal organs — is particularly metabolically active. It secretes pro-inflammatory cytokines including:

• TNF-α (Tumor Necrosis Factor-alpha): Promotes insulin resistance by impairing insulin receptor signaling
• IL-6: Pro-inflammatory signal; stimulates CRP production in the liver
• Resistin: Linked to insulin resistance
• Leptin: Pro-inflammatory at supraphysiological concentrations; promotes chronic immune activation

Adiponectin — the anti-inflammatory, insulin-sensitizing adipokine — decreases as visceral fat mass increases.

> 📌 Shoelson et al. (2007) reviewed the evidence that obesity-induced inflammation produces insulin resistance through NF-κB activation and inflammatory cytokine interference with the insulin signaling cascade — establishing the mechanistic chain from visceral fat → inflammatory cytokines → insulin receptor substrate phosphorylation impairment → insulin resistance → type 2 diabetes. [1]

Insulin Resistance and the Inflammatory Loop

Insulin resistance and chronic inflammation are mutually reinforcing. Visceral fat produces inflammation, which impairs insulin signaling. Insulin resistance causes compensatory hyperinsulinemia, which promotes further fat storage and perpetuates the inflammatory state.

The loop:

Visceral fat↑ → cytokines↑ → insulin signaling impaired → hyperinsulinemia → more fat storage → more visceral fat → cytokines↑

Breaking the loop requires reducing visceral fat mass — through caloric deficit, improved dietary composition, and exercise.

Chronic Inflammation and Cancer Risk

Chronic inflammatory signaling creates a tissue microenvironment that promotes cellular proliferation, impairs apoptosis (programmed cell death), promotes angiogenesis (tumor blood vessel formation), and can cause DNA damage through reactive oxygen species generated by immune cells.

Several cancer types show particularly strong epidemiological associations with obesity and its associated chronic inflammation: colorectal, endometrial, breast (post-menopausal), pancreatic, esophageal, and liver cancer. The mechanistic pathways differ by cancer type but share inflammatory and hormonal components.

Modifiable Drivers of Chronic Inflammation

Pro-inflammatory:

• Visceral fat accumulation
• Refined carbohydrates and added sugar (promote AGE formation and NF-κB activation)
• Omega-6 excess (arachidonic acid cascade)
• Sleep deprivation (IL-6 and CRP rise with even partial sleep restriction)
• Physical inactivity
• Smoking

Anti-inflammatory:

• Exercise (acute inflammation resolves and produces anti-inflammatory adaptation)
• Omega-3 fatty acids (EPA/DHA: compete with arachidonic acid cascade, reduce inflammatory eicosanoid production)
• Weight loss (visceral fat reduction → cytokine reduction)
• Non-processed dietary pattern (Mediterranean-type diet shows reduced inflammatory marker profiles)

---